Overview

CP-481,715 Nickel Allergy Study.

Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the suitability of contact allergy as a method for the evaluation of c-chemokine receptor-1 antagonist.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Nickel